XTX Topco’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$467K Buy
389,169
+24,431
+7% +$29.7K 0.01% 2112
2025
Q4
$358K Sell
364,738
-73,180
-17% -$87.9K 0.01% 1913
2025
Q3
$552K Buy
437,918
+5,590
+1% +$6.03K 0.03% 996
2025
Q2
$484K Sell
432,328
-26,980
-6% -$31.4K 0.02% 1123
2025
Q1
$363K Buy
459,308
+209,508
+84% +$257K 0.02% 1262
2024
Q4
$412K Buy
+249,800
New +$629K 0.03% 941
2024
Q3
Sell
-33,898
Closed -$111K 2237
2024
Q2
$111K Buy
33,898
+16,510
+95% +$72.3K 0.01% 1395
2024
Q1
$128K Buy
+17,388
New +$108K 0.02% 1307
2023
Q4
Sell
-192,920
Closed -$409K 1745
2023
Q3
$409K Buy
192,920
+171,321
+793% +$568K 0.07% 525
2023
Q2
$103K Sell
21,599
-6,591
-23% -$36.4K 0.02% 1159
2023
Q1
$161K Sell
28,190
-76,000
-73% -$459K 0.03% 1010
2022
Q4
$1.05M Buy
104,190
+83,670
+408% +$1.57M 0.22% 76
2022
Q3
$460K Buy
+20,520
New +$593K 0.11% 275
2021
Q3
Sell
-5,039
Closed -$437K 783
2021
Q2
$437K Buy
+5,039
New +$406K 0.15% 224

Other funds holding FATE